Nuvation Bio NUVB
NYSE NUVB
$5.72 +0.11 (+1.87%)
As of: Sep 30, 2026 · 1:07 PM EDT

Nuvation Bio Inc. (NUVB) Revenue (2024 - 2026)

Updated

Nuvation Bio (NUVB) reported Revenue of $31.69 million for Q2 2026, up 555.6% from $4.83 million a year earlier but down 61.9% from the prior quarter.

Analysis

Nuvation Bio Inc. (NUVB) Revenue (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nuvation Bio's Revenue came in at $169.9 million; for FY2025, it came in at $62.9 million, up 699.0% from FY2024.

  • By year, Revenue came in at $7.87 million in FY2024.
  • Five-year quarterly Revenue spans a low of $727,000 in Q3 2024 and a high of $83.23 million in Q1 2026.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $83.23 million (Q1 2026), $41.87 million (Q4 2025) and $13.12 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.69 Mn
Mar 31, 2026 83.23 Mn
Dec 31, 2025 41.87 Mn
Sep 30, 2025 13.12 Mn
Jun 30, 2025 4.83 Mn
Mar 31, 2025 3.08 Mn
Dec 31, 2024 5.71 Mn
Sep 30, 2024 727,000.00
Jun 30, 2024 1.44 Mn
API Access

Nuvation Bio Inc. Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=NUVB&period=max&api_key=YOUR_API_KEY